SlideShare a Scribd company logo
2-day In-person Seminar:
Knowledge, a Way Forward…
Overview of Device Regulation - FDA
Boston, MA
June 22nd & 23rd, 2017
8:30 AM to 5:30 PM
Thomas E. Colonna
Price: $1,295.00
(Seminar for One Delegate)
Register now and save $200. (Early Bird)
**Please note the registration will be closed 2 days
(48 Hours) prior to the date of the seminar.
Price
Overview :
Global
CompliancePanel
Dr. Thomas E. Colonna earned a bachelor of science
in microbiology from the University of Sciences in Philadelphia (formerly
the Philadelphia College of Pharmacy and Science), a Ph.D. in
molecular biology from the Johns Hopkins University, and a law degree
from the Georgetown University Law Center. In addition to his
consulting activities, Dr. Colonna is the Director of the MS in Regulatory
Science and MS in Food Safety Regulation programs at Johns Hopkins
University.
Dr. Colonna provides consulting services in the scientific and regulatory
aspects of a wide range of medical devices and biologics with particular
expertise in the areas of in vitro diagnostics (ELISA-based, PCR-based,
SNPs, microarrays, and pharmacogenomics), medical device software
(including bioinformatics), and biotechnology-based products.
This course provides a basic description of an FDA regulatory strategy
for medical devices and explains the relationships between regulatory
strategy and product development. It offers guidelines for developing
successful strategies for medical devices, including definitions and
classifications, elements of regulatory strategy, sources of regulatory
intelligence, selection of development and product clearance/approval
pathways.
$6,475.00
Price: $3,885.00 You Save: $2,590.0 (40%)*
Register for 5 attendees
Founder, Biotech Consultant LLC
Global
CompliancePanel
Agenda:
Day One Day Two
2-day In-person Seminar:
Overview of Device Regulation - FDA
Lecture 1: Overview of FDA Medical
Device Regulation 9 am - 10.30 am
Registration & Breakfast 8.30 am - 9.00 am
Lecture 2: Overview of FDA Medical
Device 510(k) Premarket
Notification Process
11.00 am - 12.30pm
Break 10.30am - 11.00 am
Lecture 3: Overview of FDA Medical
Device PreMarket Application
Process
1.30 pm - 3.00 pm
Lunch 12.30 pm - 1.30 pm
Lecture 4: Overview of FDA Device
Manufacturing Issues 3.30 pm - 5.00 pm
Break 3.00 pm - 3.30 pm
Lecture 5: Q & A 5.00 pm - 5.30 pm
Lecture 1: Overview of In Vitro
Diagnostic Regulation 9 am - 10.30 am
Registration & Breakfast 8.30 am - 9.00 am
Lecture 2: Overview of Biomedical
Software Regulation 11.00 am - 12.30pm
Break 10.30am - 11.00 am
Lecture 3: Overview of FDA Medical
Device Post-Market
Surveillance
1.30 pm - 3.00 pm
Lunch 12.30 pm - 1.30 pm
Lecture 4: Overview of Device
Regulatory Strategies 3.30 pm - 5.00 pm
Break 3.00 pm - 3.30 pm
Lecture 5: Q & A 5.00 pm - 5.30 pm
Why should you attend:
This course provides a basic description of an FDA
regulatory strategy for medical devices and
explains the relationships between regulatory
strategy and product development. It offers
guidelines for developing successful strategies for
medical devices, including definitions and
classifications, elements of regulatory strategy,
sources of regulatory intelligence, selection of
development and product clearance/approval
pathways.
Who Will Benefit:
 Regulatory professionals working in the medical
device field
Areas Covered in the Session:
 Describe the elements impacting the definition
and classification of medical devices
 Determine the points to consider in the
development of a regulatory strategy
 Define the tools for regulatory strategy
development
 Recognize sources of regulatory and competitive
intelligence
 Identify the elements of a regulatory plan
 Apply regulatory principles to develop a regulatory
plan
Global
CompliancePanel
www.globalcompliancepanel.com
Kindly get in touch with us for any help or
information.
Look forward to meeting you at the seminar
GlobalCompliancePanel
What You will get
Special price on future seminars by
GlobalCompliancePanel.
Networking with industry's top notch professionals
7
9
1 Learning Objectives
2 Participation certificates
Interactive sessions with the US expert
Post event email assistance to your queries.
Special price on future purchase of web
based trainings.
Special price on future consulting or expertise
services.
3
4
5
6
Seminar Kit – includes presentation handout,
ID card, brochure, trainings catalog, notepad
and pen.
8
Contact Information: Event Coordinator
NetZealous LLC, DBA GlobalCompliancePanel
161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA
Toll free: +1-800-447-9407
Fax: 302 288 6884
Email: support@globalcompliancepanel.com
10%
20%
25%
30%
2 Attendees to get offer
3 to 6 Attendees to get offer
7 to 10 Attendees to get offer
10+ Attendees to get offer
Group Participation
Payment Option
1 Credit Card: Use the Link to make Payment by
Visa/Master/American Express card click on the
register now link
2 Check: Kindly make the check payable to
NetZealous DBA GlobalCompliancePanel and
mailed to 161 Mission Falls Lane, Suite 216,
Fremont, CA 94539, USA
PO: Please drop an email to
support@globalcompliancepanel.com or call the
our toll free +1-800-447-9407 for the invoice and
you may fax the PO to 302 288 6884
Wire Transfer: Please drop an email to
support@globalcompliancepanel.com or call our
toll free +1-800-447-9407 for the wire transfer
information
3
4
2-day In-person Seminar:
Overview of Device Regulation - FDA

More Related Content

Similar to Overview of device regulation fda

Laboratory, medical and device performance and validation following regulator...
Laboratory, medical and device performance and validation following regulator...Laboratory, medical and device performance and validation following regulator...
Laboratory, medical and device performance and validation following regulator...
GlobalCompliancePanel
 
New fda-fsma-rules-human-animal-foods-seattle
New fda-fsma-rules-human-animal-foods-seattleNew fda-fsma-rules-human-animal-foods-seattle
New fda-fsma-rules-human-animal-foods-seattle
GlobalCompliancePanel
 
The new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairsThe new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairs
GlobalCompliancePanel
 
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical TrialsFDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
GlobalCompliancePanel
 
Fda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trialsFda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trials
GlobalCompliancePanel
 
Internal Auditing for the Medical Device Industry
Internal Auditing for the Medical Device IndustryInternal Auditing for the Medical Device Industry
Internal Auditing for the Medical Device Industry
GlobalCompliancePanel
 
Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.
OnlineCompliance Panel
 
Food safety-controls-salt-lake-city-ut
Food safety-controls-salt-lake-city-utFood safety-controls-salt-lake-city-ut
Food safety-controls-salt-lake-city-ut
GlobalCompliancePanel
 
Fda data-integrity-21-cfr-11-switzerland
Fda data-integrity-21-cfr-11-switzerlandFda data-integrity-21-cfr-11-switzerland
Fda data-integrity-21-cfr-11-switzerland
GlobalCompliancePanel
 
Fda data-integrity-21-cfr-11-singapore
Fda data-integrity-21-cfr-11-singaporeFda data-integrity-21-cfr-11-singapore
Fda data-integrity-21-cfr-11-singapore
GlobalCompliancePanel
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
GlobalCompliancePanel
 
Requirements for Establishing an Effective Cleaning Validation Program
Requirements for Establishing an Effective Cleaning Validation ProgramRequirements for Establishing an Effective Cleaning Validation Program
Requirements for Establishing an Effective Cleaning Validation Program
GlobalCompliancePanel
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the eu
GlobalCompliancePanel
 
New fda fsma rules on the sanitary transportation of human and animal foods
New fda fsma rules on the sanitary transportation of human and animal foodsNew fda fsma rules on the sanitary transportation of human and animal foods
New fda fsma rules on the sanitary transportation of human and animal foods
GlobalCompliancePanel
 
Applied statistics-scientists-engineers-sfo-ca
Applied statistics-scientists-engineers-sfo-caApplied statistics-scientists-engineers-sfo-ca
Applied statistics-scientists-engineers-sfo-ca
GlobalCompliancePanel
 
Regulatory requirements-san-diego-ca
Regulatory requirements-san-diego-caRegulatory requirements-san-diego-ca
Regulatory requirements-san-diego-ca
GlobalCompliancePanel
 
Applied Statistics for Scientists and Engineers
Applied Statistics for Scientists and EngineersApplied Statistics for Scientists and Engineers
Applied Statistics for Scientists and Engineers
GlobalCompliancePanel
 
Medical device-summit-2015-brochure
Medical device-summit-2015-brochureMedical device-summit-2015-brochure
Medical device-summit-2015-brochure
pradeepnazre
 
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsDiscovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Jaime Hodges
 
Texting and E-mail with Patients: Patient Requests and Complying with HIPAA
Texting and E-mail with Patients: Patient Requests and Complying with HIPAATexting and E-mail with Patients: Patient Requests and Complying with HIPAA
Texting and E-mail with Patients: Patient Requests and Complying with HIPAA
GlobalCompliancePanel
 

Similar to Overview of device regulation fda (20)

Laboratory, medical and device performance and validation following regulator...
Laboratory, medical and device performance and validation following regulator...Laboratory, medical and device performance and validation following regulator...
Laboratory, medical and device performance and validation following regulator...
 
New fda-fsma-rules-human-animal-foods-seattle
New fda-fsma-rules-human-animal-foods-seattleNew fda-fsma-rules-human-animal-foods-seattle
New fda-fsma-rules-human-animal-foods-seattle
 
The new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairsThe new clinical trials regulation and regulatory affairs
The new clinical trials regulation and regulatory affairs
 
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical TrialsFDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials
 
Fda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trialsFda's gmp expectations for phase i and first in-man clinical trials
Fda's gmp expectations for phase i and first in-man clinical trials
 
Internal Auditing for the Medical Device Industry
Internal Auditing for the Medical Device IndustryInternal Auditing for the Medical Device Industry
Internal Auditing for the Medical Device Industry
 
Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.Quality system regulation equipment and facilities controls subsystem.
Quality system regulation equipment and facilities controls subsystem.
 
Food safety-controls-salt-lake-city-ut
Food safety-controls-salt-lake-city-utFood safety-controls-salt-lake-city-ut
Food safety-controls-salt-lake-city-ut
 
Fda data-integrity-21-cfr-11-switzerland
Fda data-integrity-21-cfr-11-switzerlandFda data-integrity-21-cfr-11-switzerland
Fda data-integrity-21-cfr-11-switzerland
 
Fda data-integrity-21-cfr-11-singapore
Fda data-integrity-21-cfr-11-singaporeFda data-integrity-21-cfr-11-singapore
Fda data-integrity-21-cfr-11-singapore
 
Fda at-my-facility-cape-town
Fda at-my-facility-cape-townFda at-my-facility-cape-town
Fda at-my-facility-cape-town
 
Requirements for Establishing an Effective Cleaning Validation Program
Requirements for Establishing an Effective Cleaning Validation ProgramRequirements for Establishing an Effective Cleaning Validation Program
Requirements for Establishing an Effective Cleaning Validation Program
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the eu
 
New fda fsma rules on the sanitary transportation of human and animal foods
New fda fsma rules on the sanitary transportation of human and animal foodsNew fda fsma rules on the sanitary transportation of human and animal foods
New fda fsma rules on the sanitary transportation of human and animal foods
 
Applied statistics-scientists-engineers-sfo-ca
Applied statistics-scientists-engineers-sfo-caApplied statistics-scientists-engineers-sfo-ca
Applied statistics-scientists-engineers-sfo-ca
 
Regulatory requirements-san-diego-ca
Regulatory requirements-san-diego-caRegulatory requirements-san-diego-ca
Regulatory requirements-san-diego-ca
 
Applied Statistics for Scientists and Engineers
Applied Statistics for Scientists and EngineersApplied Statistics for Scientists and Engineers
Applied Statistics for Scientists and Engineers
 
Medical device-summit-2015-brochure
Medical device-summit-2015-brochureMedical device-summit-2015-brochure
Medical device-summit-2015-brochure
 
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug TargetsDiscovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
Discovery on Target 2014 - The Industry's Preeminent Event on Novel Drug Targets
 
Texting and E-mail with Patients: Patient Requests and Complying with HIPAA
Texting and E-mail with Patients: Patient Requests and Complying with HIPAATexting and E-mail with Patients: Patient Requests and Complying with HIPAA
Texting and E-mail with Patients: Patient Requests and Complying with HIPAA
 

More from GlobalCompliancePanel

Computer system validation course pdf september 2017
Computer system validation course   pdf september 2017Computer system validation course   pdf september 2017
Computer system validation course pdf september 2017
GlobalCompliancePanel
 
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal FoodsNew FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
GlobalCompliancePanel
 
HIPAA Compliance Requirements for Business Associates
HIPAA Compliance Requirements for Business AssociatesHIPAA Compliance Requirements for Business Associates
HIPAA Compliance Requirements for Business Associates
GlobalCompliancePanel
 
Statistical Methods: A Visual Approach
Statistical Methods: A Visual ApproachStatistical Methods: A Visual Approach
Statistical Methods: A Visual Approach
GlobalCompliancePanel
 
European regulatory affairs process seminar pdf
European regulatory affairs process   seminar pdfEuropean regulatory affairs process   seminar pdf
European regulatory affairs process seminar pdf
GlobalCompliancePanel
 
The Challenges of an Effective Change Control Program and How to Address OOS ...
The Challenges of an Effective Change Control Program and How to Address OOS ...The Challenges of an Effective Change Control Program and How to Address OOS ...
The Challenges of an Effective Change Control Program and How to Address OOS ...
GlobalCompliancePanel
 
14 new fda fsma rules on the sanitary transportation of human and animal foods
14 new fda fsma rules on the sanitary transportation of human and animal foods14 new fda fsma rules on the sanitary transportation of human and animal foods
14 new fda fsma rules on the sanitary transportation of human and animal foods
GlobalCompliancePanel
 
13 european regulatory procedures comprehensive overview of ema and national...
13 european regulatory procedures  comprehensive overview of ema and national...13 european regulatory procedures  comprehensive overview of ema and national...
13 european regulatory procedures comprehensive overview of ema and national...
GlobalCompliancePanel
 
hipaa 2017 under trump what to expect and how to comply
hipaa 2017 under trump  what to expect and how to complyhipaa 2017 under trump  what to expect and how to comply
hipaa 2017 under trump what to expect and how to comply
GlobalCompliancePanel
 
the challenges of an effective change control program and how to address oos ...
the challenges of an effective change control program and how to address oos ...the challenges of an effective change control program and how to address oos ...
the challenges of an effective change control program and how to address oos ...
GlobalCompliancePanel
 
hipaa compliance requirements for business associates
hipaa compliance requirements for business associateshipaa compliance requirements for business associates
hipaa compliance requirements for business associates
GlobalCompliancePanel
 
documenting software for fda submissions
documenting software for fda submissionsdocumenting software for fda submissions
documenting software for fda submissions
GlobalCompliancePanel
 
statistical methods a visual approach
statistical methods a visual approachstatistical methods a visual approach
statistical methods a visual approach
GlobalCompliancePanel
 
What to expect in a federal hipaa audit & how to avoid audit
What to expect in a federal hipaa audit & how to avoid auditWhat to expect in a federal hipaa audit & how to avoid audit
What to expect in a federal hipaa audit & how to avoid audit
GlobalCompliancePanel
 
Validation and part 11 compliance of computer systems and data
Validation and part 11 compliance of computer systems and dataValidation and part 11 compliance of computer systems and data
Validation and part 11 compliance of computer systems and data
GlobalCompliancePanel
 
The complete payroll law
The complete payroll lawThe complete payroll law
The complete payroll law
GlobalCompliancePanel
 
Statistics for the non statistician
Statistics for the non statisticianStatistics for the non statistician
Statistics for the non statistician
GlobalCompliancePanel
 
Safety management and osha compliance
Safety management and osha complianceSafety management and osha compliance
Safety management and osha compliance
GlobalCompliancePanel
 
Modern hipaa compliance managing privacy, security, and breach notification...
Modern hipaa compliance   managing privacy, security, and breach notification...Modern hipaa compliance   managing privacy, security, and breach notification...
Modern hipaa compliance managing privacy, security, and breach notification...
GlobalCompliancePanel
 
Master hipaa compliance in six steps
Master hipaa compliance in six stepsMaster hipaa compliance in six steps
Master hipaa compliance in six steps
GlobalCompliancePanel
 

More from GlobalCompliancePanel (20)

Computer system validation course pdf september 2017
Computer system validation course   pdf september 2017Computer system validation course   pdf september 2017
Computer system validation course pdf september 2017
 
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal FoodsNew FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
New FDA FSMA Rules on the Sanitary Transportation of Human and Animal Foods
 
HIPAA Compliance Requirements for Business Associates
HIPAA Compliance Requirements for Business AssociatesHIPAA Compliance Requirements for Business Associates
HIPAA Compliance Requirements for Business Associates
 
Statistical Methods: A Visual Approach
Statistical Methods: A Visual ApproachStatistical Methods: A Visual Approach
Statistical Methods: A Visual Approach
 
European regulatory affairs process seminar pdf
European regulatory affairs process   seminar pdfEuropean regulatory affairs process   seminar pdf
European regulatory affairs process seminar pdf
 
The Challenges of an Effective Change Control Program and How to Address OOS ...
The Challenges of an Effective Change Control Program and How to Address OOS ...The Challenges of an Effective Change Control Program and How to Address OOS ...
The Challenges of an Effective Change Control Program and How to Address OOS ...
 
14 new fda fsma rules on the sanitary transportation of human and animal foods
14 new fda fsma rules on the sanitary transportation of human and animal foods14 new fda fsma rules on the sanitary transportation of human and animal foods
14 new fda fsma rules on the sanitary transportation of human and animal foods
 
13 european regulatory procedures comprehensive overview of ema and national...
13 european regulatory procedures  comprehensive overview of ema and national...13 european regulatory procedures  comprehensive overview of ema and national...
13 european regulatory procedures comprehensive overview of ema and national...
 
hipaa 2017 under trump what to expect and how to comply
hipaa 2017 under trump  what to expect and how to complyhipaa 2017 under trump  what to expect and how to comply
hipaa 2017 under trump what to expect and how to comply
 
the challenges of an effective change control program and how to address oos ...
the challenges of an effective change control program and how to address oos ...the challenges of an effective change control program and how to address oos ...
the challenges of an effective change control program and how to address oos ...
 
hipaa compliance requirements for business associates
hipaa compliance requirements for business associateshipaa compliance requirements for business associates
hipaa compliance requirements for business associates
 
documenting software for fda submissions
documenting software for fda submissionsdocumenting software for fda submissions
documenting software for fda submissions
 
statistical methods a visual approach
statistical methods a visual approachstatistical methods a visual approach
statistical methods a visual approach
 
What to expect in a federal hipaa audit & how to avoid audit
What to expect in a federal hipaa audit & how to avoid auditWhat to expect in a federal hipaa audit & how to avoid audit
What to expect in a federal hipaa audit & how to avoid audit
 
Validation and part 11 compliance of computer systems and data
Validation and part 11 compliance of computer systems and dataValidation and part 11 compliance of computer systems and data
Validation and part 11 compliance of computer systems and data
 
The complete payroll law
The complete payroll lawThe complete payroll law
The complete payroll law
 
Statistics for the non statistician
Statistics for the non statisticianStatistics for the non statistician
Statistics for the non statistician
 
Safety management and osha compliance
Safety management and osha complianceSafety management and osha compliance
Safety management and osha compliance
 
Modern hipaa compliance managing privacy, security, and breach notification...
Modern hipaa compliance   managing privacy, security, and breach notification...Modern hipaa compliance   managing privacy, security, and breach notification...
Modern hipaa compliance managing privacy, security, and breach notification...
 
Master hipaa compliance in six steps
Master hipaa compliance in six stepsMaster hipaa compliance in six steps
Master hipaa compliance in six steps
 

Overview of device regulation fda

  • 1. 2-day In-person Seminar: Knowledge, a Way Forward… Overview of Device Regulation - FDA Boston, MA June 22nd & 23rd, 2017 8:30 AM to 5:30 PM Thomas E. Colonna Price: $1,295.00 (Seminar for One Delegate) Register now and save $200. (Early Bird) **Please note the registration will be closed 2 days (48 Hours) prior to the date of the seminar. Price Overview : Global CompliancePanel Dr. Thomas E. Colonna earned a bachelor of science in microbiology from the University of Sciences in Philadelphia (formerly the Philadelphia College of Pharmacy and Science), a Ph.D. in molecular biology from the Johns Hopkins University, and a law degree from the Georgetown University Law Center. In addition to his consulting activities, Dr. Colonna is the Director of the MS in Regulatory Science and MS in Food Safety Regulation programs at Johns Hopkins University. Dr. Colonna provides consulting services in the scientific and regulatory aspects of a wide range of medical devices and biologics with particular expertise in the areas of in vitro diagnostics (ELISA-based, PCR-based, SNPs, microarrays, and pharmacogenomics), medical device software (including bioinformatics), and biotechnology-based products. This course provides a basic description of an FDA regulatory strategy for medical devices and explains the relationships between regulatory strategy and product development. It offers guidelines for developing successful strategies for medical devices, including definitions and classifications, elements of regulatory strategy, sources of regulatory intelligence, selection of development and product clearance/approval pathways. $6,475.00 Price: $3,885.00 You Save: $2,590.0 (40%)* Register for 5 attendees Founder, Biotech Consultant LLC
  • 2. Global CompliancePanel Agenda: Day One Day Two 2-day In-person Seminar: Overview of Device Regulation - FDA Lecture 1: Overview of FDA Medical Device Regulation 9 am - 10.30 am Registration & Breakfast 8.30 am - 9.00 am Lecture 2: Overview of FDA Medical Device 510(k) Premarket Notification Process 11.00 am - 12.30pm Break 10.30am - 11.00 am Lecture 3: Overview of FDA Medical Device PreMarket Application Process 1.30 pm - 3.00 pm Lunch 12.30 pm - 1.30 pm Lecture 4: Overview of FDA Device Manufacturing Issues 3.30 pm - 5.00 pm Break 3.00 pm - 3.30 pm Lecture 5: Q & A 5.00 pm - 5.30 pm Lecture 1: Overview of In Vitro Diagnostic Regulation 9 am - 10.30 am Registration & Breakfast 8.30 am - 9.00 am Lecture 2: Overview of Biomedical Software Regulation 11.00 am - 12.30pm Break 10.30am - 11.00 am Lecture 3: Overview of FDA Medical Device Post-Market Surveillance 1.30 pm - 3.00 pm Lunch 12.30 pm - 1.30 pm Lecture 4: Overview of Device Regulatory Strategies 3.30 pm - 5.00 pm Break 3.00 pm - 3.30 pm Lecture 5: Q & A 5.00 pm - 5.30 pm Why should you attend: This course provides a basic description of an FDA regulatory strategy for medical devices and explains the relationships between regulatory strategy and product development. It offers guidelines for developing successful strategies for medical devices, including definitions and classifications, elements of regulatory strategy, sources of regulatory intelligence, selection of development and product clearance/approval pathways. Who Will Benefit:  Regulatory professionals working in the medical device field Areas Covered in the Session:  Describe the elements impacting the definition and classification of medical devices  Determine the points to consider in the development of a regulatory strategy  Define the tools for regulatory strategy development  Recognize sources of regulatory and competitive intelligence  Identify the elements of a regulatory plan  Apply regulatory principles to develop a regulatory plan
  • 3. Global CompliancePanel www.globalcompliancepanel.com Kindly get in touch with us for any help or information. Look forward to meeting you at the seminar GlobalCompliancePanel What You will get Special price on future seminars by GlobalCompliancePanel. Networking with industry's top notch professionals 7 9 1 Learning Objectives 2 Participation certificates Interactive sessions with the US expert Post event email assistance to your queries. Special price on future purchase of web based trainings. Special price on future consulting or expertise services. 3 4 5 6 Seminar Kit – includes presentation handout, ID card, brochure, trainings catalog, notepad and pen. 8 Contact Information: Event Coordinator NetZealous LLC, DBA GlobalCompliancePanel 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA Toll free: +1-800-447-9407 Fax: 302 288 6884 Email: support@globalcompliancepanel.com 10% 20% 25% 30% 2 Attendees to get offer 3 to 6 Attendees to get offer 7 to 10 Attendees to get offer 10+ Attendees to get offer Group Participation Payment Option 1 Credit Card: Use the Link to make Payment by Visa/Master/American Express card click on the register now link 2 Check: Kindly make the check payable to NetZealous DBA GlobalCompliancePanel and mailed to 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA PO: Please drop an email to support@globalcompliancepanel.com or call the our toll free +1-800-447-9407 for the invoice and you may fax the PO to 302 288 6884 Wire Transfer: Please drop an email to support@globalcompliancepanel.com or call our toll free +1-800-447-9407 for the wire transfer information 3 4 2-day In-person Seminar: Overview of Device Regulation - FDA